Safe and Effective Management of the Obese Patient

作者: Maria L. Collazo-Clavell

DOI: 10.4065/74.12.1255

关键词: Weight gainObesityType 2 Diabetes MellitusIntensive care medicineBody mass indexOverweightSurgeryWeight lossMedicineDyslipidemiaPublic health

摘要: The prevalence of overweight and obesity has increased dramatically in the recent decades, is now a major public health problem. Obesity negatively influences an individual's by increasing mortality raising risk for multiple medical conditions such as type 2 diabetes mellitus, hypertension, dyslipidemia, coronary heart disease. In addition, obese individual often brunt social discrimination. Weight loss been shown to reduce many these comorbid conditions. A multifaceted approach patient should include identifying potential causes weight gain, outlining that would benefit loss, tailoring program safe effective individual. Components successful dietary intervention, recommendations physical activity, behavior modification, and, select group patients, pharmacologic or surgical intervention.

参考文章(9)
CHESTER J ZELASKO, Exercise for weight loss: what are the facts? Journal of The American Dietetic Association. ,vol. 95, pp. 1414- 1417 ,(1995) , 10.1016/S0002-8223(95)00371-1
Bruno M. Balsiger, Enrique Luque-De Leon, Michael G. Sarr, Surgical treatment of obesity: who is an appropriate candidate? Mayo Clinic proceedings. ,vol. 72, pp. 551- 558 ,(1997) , 10.4065/72.6.551
Michael H. Davidson, Jonathan Hauptman, Mario DiGirolamo, John P. Foreyt, Charles H. Halsted, David Heber, Douglas C. Heimburger, Charles P. Lucas, David C. Robbins, Jain Chung, Steven B. Heymsfield, Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat JAMA. ,vol. 281, pp. 235- 242 ,(1999) , 10.1001/JAMA.281.3.235
Lars Sjöström, Aila Rissanen, Teis Andersen, Mark Boldrin, Alain Golay, Hans PF Koppeschaar, Michel Krempf, Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients The Lancet. ,vol. 352, pp. 167- 172 ,(1998) , 10.1016/S0140-6736(97)11509-4
F. Xavier Pi-Sunyer, Medical Hazards of Obesity Annals of Internal Medicine. ,vol. 119, pp. 655- 660 ,(1993) , 10.7326/0003-4819-119-7_PART_2-199310011-00006
Telch Cf, Arnow B, Eldredge K, Marnell M, Agras Ws, One-Year Follow-Up of Cognitive-Behavioral Therapy for Obese Individuals With Binge Eating Disorder Journal of Consulting and Clinical Psychology. ,vol. 65, pp. 343- 347 ,(1997) , 10.1037//0022-006X.65.2.343
M. E. J. Lean, Sibutramine--a review of clinical efficacy. International Journal of Obesity. ,vol. 21, ,(1997)